Bausch Health Companies (BHC) Shares Outstanding (Weighted Average) (2009 - 2026)

Bausch Health Companies has disclosed Shares Outstanding (Weighted Average) across 16 years of filings, most recently posting $372.8 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $372.8 million, up 0.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $372.8 million (up 0.87% YoY), and the FY2025 annual result was $370.9 million, up 0.79% from the prior year.
• Shares Outstanding (Weighted Average) came in at $372.8 million for Q1 2026 at Bausch Health Companies, up from $370.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $372.8 million in Q1 2026 to a low of $360.8 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $366.8 million (2024), against an average of $366.5 million.
• Across the five-year window, Shares Outstanding (Weighted Average) climbed 1.12% in 2022 and increased 0.55% in 2023, its largest moves.
• Bausch Health Companies' Shares Outstanding (Weighted Average) stood at $362.0 million in 2022, then climbed by 0.8% to $364.9 million in 2023, then grew by 0.85% to $368.0 million in 2024, then grew by 0.79% to $370.9 million in 2025, then increased by 0.51% to $372.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $372.8 million (Q1 2026), $370.9 million (Q4 2025), and $370.6 million (Q3 2025), per Business Quant data.